Raffles Medical Group Ltd
SGX:BSL

Watchlist Manager
Raffles Medical Group Ltd Logo
Raffles Medical Group Ltd
SGX:BSL
Watchlist
Price: 0.98 SGD Market Closed
Market Cap: 1.8B SGD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+15%
Operating Income
Forecast
+23%
Net Income
Forecast
+39%

Wall Street
Price Targets

BSL Price Targets Summary
Raffles Medical Group Ltd

Wall Street analysts forecast BSL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSL is 1.12 SGD with a low forecast of 1.03 SGD and a high forecast of 1.26 SGD.

BSL Lowest Forecast
Wall Street Target
1.03 SGD
5% Upside
BSL Average Forecast
Wall Street Target
1.12 SGD
15% Upside
BSL Highest Forecast
Wall Street Target
1.26 SGD
29% Upside
Lowest
Price Target
1.03 SGD
5% Upside
Average
Price Target
1.12 SGD
15% Upside
Highest
Price Target
1.26 SGD
29% Upside
Raffles Medical Group Ltd Competitors:
Price Targets
REG
Regis Healthcare Ltd
3% Upside
HCG
Healthcare Global Enterprises Ltd
12% Upside
4005
National Medical Care Company JSC
1% Downside
R
RAINBOW
Rainbow Children's Medicare Ltd
19% Upside
REG
Regis Healthcare Ltd
3% Upside
HCG
Healthcare Global Enterprises Ltd
12% Upside
4005
National Medical Care Company JSC
1% Downside
R
RAINBOW
Rainbow Children's Medicare Ltd
19% Upside
P
PNTG
Pennant Group Inc
16% Upside

Revenue
Forecast

Revenue Estimate
Raffles Medical Group Ltd

For the last 8 years the compound annual growth rate for Raffles Medical Group Ltd's revenue is 6%. The projected CAGR for the next 3 years is 5%.

6%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Raffles Medical Group Ltd

For the last 8 years the compound annual growth rate for Raffles Medical Group Ltd's operating income is 0%. The projected CAGR for the next 3 years is 8%.

0%
Past Growth
8%
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Raffles Medical Group Ltd

For the last 8 years the compound annual growth rate for Raffles Medical Group Ltd's net income is -1%. The projected CAGR for the next 3 years is 12%.

-1%
Past Growth
12%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

See Also

Summary
BSL intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSL stock valuation using valuation multiples.
Wall Street Estimates
BSL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BSL's stock price target?
Price Target
1.12 SGD

According to Wall Street analysts, the average 1-year price target for BSL is 1.12 SGD with a low forecast of 1.03 SGD and a high forecast of 1.26 SGD.

What is Raffles Medical Group Ltd's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Raffles Medical Group Ltd's revenue is 6%. The projected CAGR for the next 3 years is 5%.

What is Raffles Medical Group Ltd's Operating Income forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Raffles Medical Group Ltd's operating income is 0%. The projected CAGR for the next 3 years is 8%.

What is Raffles Medical Group Ltd's Net Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Raffles Medical Group Ltd's net income is -1%. The projected CAGR for the next 3 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.